<DOC>
	<DOC>NCT00171847</DOC>
	<brief_summary>Phase IV trial to investigate the effect of the combination of Letrozole with trastuzumab in metastatic breast cancer patients</brief_summary>
	<brief_title>Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Postmenopausal Her2 overexpression and ER and/or PgR positive Metastatic Breast Cancer Previous treatment with trastuzumab Significant Liver or renal impairment Erbb2 negative and/or ER and PgR negative Other protocoldefined inclusion / exclusion criteria may apply.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Trastuzumab</keyword>
	<keyword>Letrozole</keyword>
</DOC>